Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia

Bibliographic Details
Main Author: Michael H. Davidson
Format: Article
Language:English
Published: Elsevier 2015-04-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396415000675
id doaj-35099c1bcbf544b5ab50a3cabbe472a3
record_format Article
spelling doaj-35099c1bcbf544b5ab50a3cabbe472a32020-11-25T00:07:11ZengElsevierEBioMedicine2352-39642015-04-012428410.1016/j.ebiom.2015.03.004Beta-2 Agonism: A Potential Therapeutic Target for DyslipidemiaMichael H. Davidsonhttp://www.sciencedirect.com/science/article/pii/S2352396415000675
collection DOAJ
language English
format Article
sources DOAJ
author Michael H. Davidson
spellingShingle Michael H. Davidson
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
EBioMedicine
author_facet Michael H. Davidson
author_sort Michael H. Davidson
title Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_short Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_full Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_fullStr Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_full_unstemmed Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
title_sort beta-2 agonism: a potential therapeutic target for dyslipidemia
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2015-04-01
url http://www.sciencedirect.com/science/article/pii/S2352396415000675
work_keys_str_mv AT michaelhdavidson beta2agonismapotentialtherapeutictargetfordyslipidemia
_version_ 1725419627354259456